Thrombolysis

Contributing journals to this collection:
JAMA & Archives Journals

Citations 201-210 of 392 total displayed.

Past content

Editorials
Do Transfusions Get to the Heart of the Matter?

Paul C. Hébert; Dean A. Fergusson
JAMA 2004; 292: 1610-1612. [Extract] [Full text] [PDF]  

Editorials
Measuring Race and Ethnicity: Why and How?

Margaret A. Winker
JAMA 2004; 292: 1612-1614. [Extract] [Full text] [PDF]  

Letters
Fractionating Heparin—Reply

Pranab Das; David J. Moliterno
JAMA 2004; 292: 1427-b-1428-b. [Extract] [Full text] [PDF]  

Letters
Fractionating Heparin

Ehud Arbit
JAMA 2004; 292: 1427-a. [Extract] [Full text] [PDF]  

Medical News & Perspectives
Study Reveals Ginseng Supplements May Hamper Effects of Anticlotting Drug

Mike Mitka
JAMA 2004; 292: 674. [Extract] [Full text] [PDF]  

Original Contributions
Long-term Efficacy of Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade vs Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Revascularization: REPLACE-2 Randomized Trial

A. Michael Lincoff; Neal S. Kleiman; Dean J. Kereiakes; Frederick Feit; John A. Bittl; J. Daniel Jackman; Ian J. Sarembock; David J. Cohen; Douglas Spriggs; Ramin Ebrahimi; Gadi Keren; Jeffrey Carr; Eric A. Cohen; Amadeo Betriu; Walter Desmet; Wolfgang Rutsch; Robert G. Wilcox; Pim J. de Feyter; Alec Vahanian; Eric J. Topol; for the REPLACE-2 Investigators
JAMA 2004; 292: 696-703. [Abstract] [Full text] [PDF]  

Editor's Correspondence
Improving the Definition of Heparin-Induced Thrombocytopenia

Lorenz Risch; Andreas R. Huber
Arch Intern Med 2004; 164: 1699. [Extract] [Full text] [PDF]  

Original Investigations
The Effect of Excessive Anticoagulation on Mortality and Morbidity in Hospitalized Patients With Anticoagulant-Related Major Hemorrhage

Sophia Koo; Nils Kucher; Paul L. Nguyen; John Fanikos; Peter W. Marks; Samuel Z. Goldhaber
Arch Intern Med 2004; 164: 1557-1560. [Abstract] [Full text] [PDF]  

Original Contributions
Enoxaparin vs Unfractionated Heparin in High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Managed With an Intended Early Invasive Strategy: Primary Results of the SYNERGY Randomized Trial

SYNERGY Trial Investigators
JAMA 2004; 292: 45-54. [Abstract] [Full text] [PDF]  

Original Contributions
Safety and Efficacy of Enoxaparin vs Unfractionated Heparin in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Who Receive Tirofiban and Aspirin: A Randomized Controlled Trial

Michael A. Blazing; James A. de Lemos; Harvey D. White; Keith A. A. Fox; Freek W. A. Verheugt; Diego Ardissino; Peter M. DiBattiste; Joanne Palmisano; David W. Bilheimer; Steven M. Snapinn; Karen E. Ramsey; Laura H. Gardner; Vic Hasselblad; Marc A. Pfeffer; Eldrin F. Lewis; Eugene Braunwald; Robert M. Califf; for the A to Z Investigators
JAMA 2004; 292: 55-64. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40